Posted in | News | Materials Science

Greater Pharmaceutical Adoption of Raman Spectroscopy with New USP Chapters

The NanoRam family of handheld Raman instruments is used globally for incoming raw material identification in the pharmaceutical industry.  With the growing use of handheld Raman, the pharmacopeial chapters for Raman spectroscopy have followed and added more information and guidance for system testing. The replacement of USP <1120> Raman Spectroscopy with two new chapters, USP <858> Raman Spectroscopy and USP <1858> Raman Spectroscopy – Theory and Practice went into effect, reflects the regulatory recognition of Raman spectroscopy as a valuable technology to the industry.

NanoRam and Nanoam-1064 systems are calibrated in compliance with the wavelength accuracy criteria for qualitative Raman measurements set forth by all global pharmacopeias, including the new USP <858> and <1858> chapters. The system software of the NanoRam and NanoRam-1064 includes performance validation testing using Raman shift standard materials as defined by ASTM E1840 Standard Guide for Raman Shift Standards for Spectrometer Calibration. The performance validation report shows the Raman shifts measured during the validation against the specification for the tolerances for polystyrene set forth by the USP <858>, EP, and JP Raman chapters for handheld Raman or qualitative analysis.

The NanoRam systems include a variety of sampling accessories optimized for the measurement of materials in the form of liquids, gels, powders, or solids under both a laboratory setting and demanding environmental conditions. Using the NanoRam for RMID is the first step in designing quality into pharmaceutical products by ensuring raw material quality.

See more information about B&W Tek handheld Raman and USP compliance here :

  • NanoRam (785 nm excitation, and Raman shift range 176–2900 cm-1)
  • NanoRam-1064 (1064 nm excitation, and Raman shift range 176–2500 cm-1)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Metrohm AG. (2024, March 28). Greater Pharmaceutical Adoption of Raman Spectroscopy with New USP Chapters. AZoM. Retrieved on July 24, 2024 from https://www.azom.com/news.aspx?newsID=55470.

  • MLA

    Metrohm AG. "Greater Pharmaceutical Adoption of Raman Spectroscopy with New USP Chapters". AZoM. 24 July 2024. <https://www.azom.com/news.aspx?newsID=55470>.

  • Chicago

    Metrohm AG. "Greater Pharmaceutical Adoption of Raman Spectroscopy with New USP Chapters". AZoM. https://www.azom.com/news.aspx?newsID=55470. (accessed July 24, 2024).

  • Harvard

    Metrohm AG. 2024. Greater Pharmaceutical Adoption of Raman Spectroscopy with New USP Chapters. AZoM, viewed 24 July 2024, https://www.azom.com/news.aspx?newsID=55470.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.